创新药板块近期持续走强。截至8月11日收盘，万邦医药涨20%，报70.39元/股，年内累计涨幅高达149%；百花医药走出6连板，收盘报12.75元/股，近5日涨幅60.98%；振东制药大涨14.26%，亚泰集团、甘李药业、哈药股份同步封板，板块做多情绪持续升温。 二级市场热度涌动的背后，是创新药产业基本面迎来实质性改善。2026年上半年，国内创新药行业迎来业绩兑现窗口。Wind数据显示，目前已有...
Source Link创新药板块近期持续走强。截至8月11日收盘，万邦医药涨20%，报70.39元/股，年内累计涨幅高达149%；百花医药走出6连板，收盘报12.75元/股，近5日涨幅60.98%；振东制药大涨14.26%，亚泰集团、甘李药业、哈药股份同步封板，板块做多情绪持续升温。 二级市场热度涌动的背后，是创新药产业基本面迎来实质性改善。2026年上半年，国内创新药行业迎来业绩兑现窗口。Wind数据显示，目前已有...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.